These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15000301)

  • 21. Large ascorbic acid intake.
    Poser E
    N Engl J Med; 1972 Aug; 287(8):412-3. PubMed ID: 5043534
    [No Abstract]   [Full Text] [Related]  

  • 22. [Can the administration of large doses of vitamin C have a harmful effect?].
    Wróblewski K
    Pol Merkur Lekarski; 2005 Oct; 19(112):600-3. PubMed ID: 16379336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More evidence regarding vitamin C and kidney stone risk.
    Mayo Clin Health Lett; 2013 May; 31(5):4. PubMed ID: 24701646
    [No Abstract]   [Full Text] [Related]  

  • 24. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute oxalate nephropathy after a massive intravenous dose of vitamin C.
    Wong K; Thomson C; Bailey RR; McDiarmid S; Gardner J
    Aust N Z J Med; 1994 Aug; 24(4):410-1. PubMed ID: 7980244
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
    Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation.
    Dhar NB; Grundfest S; Jones JS; Streem SB
    J Urol; 2005 Nov; 174(5):1844-6; discussion 1846. PubMed ID: 16217311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose supplementation with vitamin C--induced pediatric urolithiasis: the first case report in a child and literature review.
    Chen X; Shen L; Gu X; Dai X; Zhang L; Xu Y; Zhou P
    Urology; 2014 Oct; 84(4):922-4. PubMed ID: 25260453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug-induced calculi].
    Hammann C; Guelpa G
    Schweiz Rundsch Med Prax; 1993 Oct; 82(41):1129-32. PubMed ID: 8210886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical strategies for prevention of drug-induced urinary calculi].
    Kohjimoto Y; Sasaki Y; Hara I
    Clin Calcium; 2011 Oct; 21(10):1457-63. PubMed ID: 21960230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?
    Laube N; Hergarten S
    J Urol; 2005 Jun; 173(6):2175-7. PubMed ID: 15879882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
    Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bariatric surgery, vitamin C, and kidney stones.
    Weiss D
    Cleve Clin J Med; 2010 Dec; 77(12):844; author reply 844. PubMed ID: 21186694
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of oxalate stones from large doses of vitamin C.
    Herbert V
    N Engl J Med; 1978 Apr; 298(15):856. PubMed ID: 634328
    [No Abstract]   [Full Text] [Related]  

  • 39. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety considerations with high ascorbic acid dosage.
    Barness LA
    Ann N Y Acad Sci; 1975 Sep; 258():523-8. PubMed ID: 946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.